-The Times of India NEW DELHI: An analysis of bills from four reputed private hospitals in Delhi and NCR by the National Pharmaceutical Pricing Authority (NPPA) has revealed that they are making profits of up to 1,737% on drugs, consumables and diagnostics and that these three accounts for about 46% of a patient’s bill. The analysis, released on Tuesday, noted that “the major beneficiaries of profits in all these cases because of...
More »SEARCH RESULT
Total Matching Records found : 273
Cardiac stent price cap lowered further to Rs 28,000 -Rema Nagarajan
-The Times of India The National Pharmaceutical Pricing Authority on Monday revised the price of drug eluting stents (DES) downwards by about Rs 2,300 to just under Rs 28,000, while marginally raising the cap on bare metal stents from Rs 7,400 to Rs 7,660. These caps are excluding GST. With DES accounting for about 95% of all stents used in India, this means most stents will become cheaper. The authority, which had...
More »What the US Health Insurance Programme Can Teach India -Rama V Baru
-TheWire.in Why has India chosen the path of expanding medical insurance instead of a more comprehensive approach to health? The concern with rising inequities in access to medical care, rising out-of-pocket expenditures and unmet treatment needs have been addressed with yet another targeted medical insurance scheme for poor households. The idea of a targeted medical insurance is not new. Several southern states like Andhra Pradesh and Karnataka had introduced such schemes many...
More »China accounts for 66 per cent of India's bulk drug imports in FY'17
-PTI NEW DELHI: India's bulk drug imports from top five countries stood at Rs 18,372.54 crore in 2016-17 with China accounting for 66 per cent, Parliament was informed today. In a written reply in Lok Sabha, Minister of State, Chemicals and Fertilisers Mansukh L Mandaviya said the other four major countries from where India imports bulk drugs are Germany, the US, Italy and Singapore. India's import of active pharmaceutical ingredients (API) from China...
More »The Truth Behind the Gujarat Growth Model -Indira Hirway
-TheWire.in After huge incentives to corporate units, the Gujarat government is left with limited funds for education, health, environment and employment for the masses. What is the Gujarat model? In simple terms, it refers to a period from 2002-03 to 20011-12 during which Gujarat experienced a quantum jump in its growth rate. The driving force was the then chief minister Narendra Modi’s innovative interpretation of neoliberal policies. The growth strategy had three major...
More »
